Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01824823
Title Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eastern Cooperative Oncology Group
Indications

hypopharynx cancer

oropharynx cancer

oral squamous cell carcinoma

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

Afatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.